Triple Hair Inc.

Founded in 2014 by Houfar Sekhavat and Peter Ford and based in New Brunswick, Canada, Triple Hair Inc. operates as a researcher and developer of topical treatments for hair growth that offer treatment to address alopecia. In June 2024, Triple Hair Inc. raised USD 4 million in venture funding from Prevail Partners, the New Brunswick Innovation Fund, and Investissement Québec.

As of 2024, the company is led by its CEO and president, Jean-Philippe Gravel. The company’s primary product is the Plenty hair densifying spray, which features the drug-free hair growth formula Therapy-16. This product is specifically designed to support women with mild-to-moderate alopecia. Similarly, for men, the firm offers the RIZN hair density spray, which also incorporates the Therapy-16 formula.

This product line aims to stop hair shedding and stimulate hair regrowth without the need for prescription medications. Triple Hair's portfolio also encompasses Therapy-07, a prescription-based triple combination therapy designed to promote hair regrowth in men with androgenic alopecia. This treatment halts hair loss, stimulates regrowth, and enhances the appearance of hair thickness. The organization plans to use the June 2024 funding to expedite the Phase III clinical trials for Therapy-07, its primary prescription medicine, across many nations.